Clinical Trials Logo

Clinical Trial Summary

Because of the unforeseen rate of increase in case numbers, the high rates of mortality and morbidity, and the increased socio economic load it causes, diabetes has become the most discussed chronic and widespread metabolic disease in Turkey, and throughout the World, there are focused efforts to find a solution. It is very important for a person to self-assesss and evaluate to draw a roadmap for improved outcomes in a disease with a high financial and moral burden. A nurse is not only a caregiver to patients, but also a person who guides them to increased engagement and motivation in the care of their illness. Integrative Nurse Coaching is gaining notoriaty as an effective method to improve patient engagament and motivation in self-responsibility for health. The Integrative Nurse Coach Academy in the USA carries out studies and trainings to further this improvement. With cooperation between United States and Turkish nurse colleagues, it aims to bring Integrative Nurse Coach practice to Turkey. The Integrative Nurse Coach uses the nursing process as a framework to guide nurse coaching practice. This requires a shift in traditional nursing terminology and meaning to understand and incorporate the patient's subjective experience as follows: from assessment to stablishing a relationship, identifying readiness for change and the resources available to the patient for change; from nursing diagnosis to identifying opportunities and issues; from outcomes to having the patient set the agenda for achievement of the patient's goals; from 3 planning to creating the structure of the coaching interaction; from intervention to empowering the patient to reach goals; and from evaluating to assisting the patient to determine the extent to which goals were achieved. The Theory of Integrative Nurse Coaching (TINC) , developed by the Integrative Nurse Coach Association , sheds light on this point. The TINC encompasses many holistic nursing theories and contains three concepts and five components. The three concepts are healing, metaparadigm in nursing theory (nurse, person, health, environment), and patterns of knowing in nursing (personal, empirics, aesthetics, ethical, not knowing, sociopolitical. The TINC five components include Integrative Nurse Coach Self-Development (self-reflection, self-assessment, self-evaluation self-care), Integral Perspective and Change, Integrative Lifestyle Health and Well-Being, Awareness and Choice, and Listening With Heart The five components all have equal value and form the basis for the nurse coach professional practice model. There is a parallel process of self-development for both the nurse coach and the client. The SelfDevelopment component empowers individuals (including the nurse coach) to focus on their health and wellness from an integral perspective and to identify their individual knowledge, expertise, strengths, and resources, while recognizing the fluidity of the change. The TINC is designed to guide nurse coaching practice, education, research, and health care policy. The theory emphasizes, describes, and directs the practice of nurse coaching, a recognized holistic nursing modality. It has been seen that the TINC framework is very suitable for individuals with diabetes to provide their own management.


Clinical Trial Description

This research is a quasi-experimental study in pretest-posttest design research; It will be conducted with individuals with Type 1 diabetes who applied to Ankara City Hospital Endocrine Polyclinic. The sample size required for the study was found to be 95% power at 95% confidence level and 35 individuals for high-level effect size (f=0.40). However, the aim is to reach 40 individuals with the thought that data loss may occur during the study process. Inclusion Criteria for Research; The patient; - Being between the ages of 18-65, - Having a smart phone and being able to use it actively, - Having been diagnosed with type 1 diabetes at least 1 year ago, - HbA1c > 7, - Absence of any psychiatric or mental problems, - Having the cognitive competence to answer the questions, - Being able to speak, understand and read and write Turkish - Patients who voluntarily agreed to participate in the study were included in the study. Hypotesis H0: Nurse coaching given to individuals with Type 1 Diabetes has no effect on glycemic control, fear of hypoglycemia, and risk perception. H1: Nurse coaching given to individuals with Type 1 Diabetes has an effect on glycemic control, fear of hypoglycemia and risk perception. Data collection tools Data will be collected through the Sociodemographic data collection form, the hypoglycemıc attıtudes and behavıor scale, the risk perception scale. Sociodemographic data collection form: The form created by the researcher consists of questions about the sociodemographic information of the individual. In this section, besides questions about diabetes, there are questions such as gender, weight, height, age, marital status, educational status, occupation, economic status, and place of residence. The hypoglycemıc attıtudes and behavıor scale: The scale was developed by Polonsky. The 14-item 5-point Likert-type scale has 3 sub-dimensions. Anxiety, confidence, avoidance. The score of the sub-dimensions is calculated by dividing the number of items. The risk perception scale: The scale was developed in 2007 and tested for validity and reliability. The scale is a self-report scale with 31 items that is easy to complete. Items 8,9,10,11,12, and 13 are scored inversely on the scale. The scale has 2 sub dimensions, namely risk knowledge and composite risk. These sub dimensions are evaluated separately in the scale and the total score from the scale is calculated through their total. The scores of the sub dimensions are calculated through dividing the total score by the number of items in the sub dimension. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05870280
Study type Interventional
Source Ankara Yildirim Beyazit University
Contact
Status Not yet recruiting
Phase N/A
Start date August 30, 2023
Completion date October 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A